Language Select
Logotipo de Varian

Press Releases

Octubre 08, 2019
Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla. The Varian interventional... Read more
Septiembre 23, 2019
Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section... Read more
Septiembre 16, 2019
Varian (NYSE: VAR) has named Francis R. Facchini, M.D., FSIR, as the new chief medical officer, Interventional Oncology, reporting to Dee Khuntia, Varian chief medical officer. Effective September... Read more
Septiembre 16, 2019
Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally,... Read more
Septiembre 16, 2019
Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is the smallest multi-room system available for... Read more
Septiembre 15, 2019
Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution.... Read more
Septiembre 13, 2019
Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a... Read more
Septiembre 12, 2019
Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2019 earnings release date. The Company will report results for the fourth quarter of fiscal year 2019 after market close on... Read more
Septiembre 11, 2019
Varian (NYSE: VAR) has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on... Read more
Septiembre 10, 2019
The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com